Table 4.
IGAIS 4-Point Scale 0 = No Change, 1 = Mild Improvement, 2 = Moderate Improvement, 3 = Significant Improvement |
IGAIS 5-Point Scale 1 = Very Much Improved, 2 = Marked Improvement, 3 = Improved, 4 = No Change, 5 = Worse |
||||
---|---|---|---|---|---|
Author | Outcomes (%) Day 90 |
Outcomes (%) Day 180 |
Author | Outcomes (%) Day 90 |
Outcomes (%) Day 180 |
Sasaki et al. [18] Study group 1 N = 107 |
0: – – 1: 47 2: 53 3: – – |
0: – – 1: 31 2: 69 3: – – |
Lu et al. [9] N= Day 90 21 Day 180 22 |
1: – – 2: 16 3: 68 4: 16 5: – – |
1: – – 2: 16 3: 72 4: 12 5: – – |
Sasaki et al. [18] Study group 2 N = 55 |
A 0: – – 1: 34 2: 48 3: 18 |
0: – – 1: 10.4 2: 63.4 3: 26.2 |
Fabi et al. [17] N= Day 90 16 Day 180 45 |
1: 0 2: 44 3: 37 4: 19 5: – – |
1: 13 2: 18 3: 47 4: 22 5: – – |
Ko et al. [9] Cheeks only N = 32 |
0: 9 1: 91 2: – – 3: – – |
Werschler et al. [8] N= Day 90 20 Day 180 19 |
1: 5 2: 55 3: 40 4: – – 5: – – |
1: 5 2: 53 3: 42 4: – – 5: – – |
|
Lee et al. [13] Lower face N = 12 |
0: 20 1: 20 2: 40 3: 20 |
Yalici-Armagan et al. [18] Lower face N = 24 |
1: – – 2: 4 3: 17 4: 63 5.17 |
||
Shome et al. [23] Mid and lower face N = 50 |
0: – – 1: 52 2: 24 3: 24 |
||||
Pooled Investigator Reported Scores (Converted scores) IGAIS 4- and 5-point score, all facial areas: score 0 = no change, 1 = mild improvement, 2 = moderate improvement, 3 = significant improvement, 4 = worsening. Data presented as percentage and number of cases. | |||||
Day 90 (n = 337) |
Day 180 (n = 249) |
||||
No change (0) Mild improvement (1) Moderate improvement (2) Significant improvement (3) Worsening (4) |
7% (n = 25) 47% (n = 159) 36% (n = 122) 8% (n = 26) 1% (n = 4) |
5% (n = 13) 34% (n = 84) 52% (n = 130) 8% (n = 21) 0% |